First-In-Human Pilot PET Immunoimaging Study of <sup>64</sup>Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers-Reference-Cited by-同舟云学术

First-In-Human Pilot PET Immunoimaging Study of ⁶⁴Cu-Anti-Carcinoembryonic Antigen Monoclonal Antibody (hT84.66-M5A) in Patients with Carcinoembryonic Antigen-Producing Cancers

Published:2023-02-01 Issue:1 Volume:38 Page:26-37
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Wong Jeffrey Y.C.¹²^ORCID,Yamauchi David M.³,Adhikarla Vikram⁴,Simpson Jennifer⁵,Frankel Paul H.⁴,Fong Yuman⁶,Melstrom Kurt A.⁶,Chen Yi-jen¹,Salehian Behrooz D.⁷,Woo Yanghee⁶,Dandapani Savita V.¹,Colcher David M.²,Poku Erasmus K.⁸,Yazaki Paul J.²,Wu Anna M.²,Shively John E.²^ORCID

Affiliation:

1. Department of Radiation Oncology, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

2. Department of Immunology and Theranostics, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

3. Department of Diagnostic Radiology, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

4. Department of Computational and Quantitative Medicine, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

5. Department of Clinical Trials Office, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

6. Department of Surgery, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

7. Department of Diabetes and Endocrinology, and City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

8. Department of Radiopharmacy, City of Hope National Medical Center and the Beckman Research Institute, Duarte, California, USA.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2022.0028

Reference29 articles.

1. DEMONSTRATION OF TUMOR-SPECIFIC ANTIGENS IN HUMAN COLONIC CARCINOMATA BY IMMUNOLOGICAL TOLERANCE AND ABSORPTION TECHNIQUES

2. Use of Radiolabeled Antibodies to Carcinoembryonic Antigen for the Detection and Localization of Diverse Cancers by External Photoscanning

3. Tumor Localization of Radio-Labeled Antibodies against Carcinoembryonic Antigen in Patients with Carcinoma

4. Radionuclide-Based Cancer Imaging Targeting the Carcinoembryonic Antigen

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Concept for Preoperative and Intraoperative Molecular Imaging and Detection for Assessing Extent of Disease of Solid Tumors;Oncology Reviews;2024-07-25

2. Zirconium 89 and Copper 64 for ImmunoPET: From Antibody Bioconjugation and Radiolabeling to Molecular Imaging;Pharmaceutics;2024-06-30

3. Targeting Patient-Derived Orthotopic Gastric Cancers with a Fluorescent Humanized Anti-CEA Antibody;Annals of Surgical Oncology;2024-06-18

4. CEACAM5-Targeted Immuno-PET in Androgen Receptor–Negative Prostate Cancer;Journal of Nuclear Medicine;2024-05-23

5. Advances and challenges in immunoPET methodology;Frontiers in Nuclear Medicine;2024-02-19